PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE (PACAP) MIMICS THE ACTIONS OF VASOACTIVE-INTESTINAL-PEPTIDE (VIP) ON GASTRIC CHIEF CELLS

被引：0
|
作者：
RAUFMAN, JP [1 ]
SINGH, L [1 ]
机构：
[1] SUNY HLTH SCI CTR,DEPT MED,BROOKLYN,NY
来源：
CLINICAL RESEARCH | 1992年 / 40卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A262 / A262
页数：1
相关论文
共 50 条
  • [21] Pituitary adenylate cyclase-activating peptide and vasoactive intestinal peptide receptor expression in immortalized LHRH neurons
    Olcese, J
    McArdle, CA
    Middendorff, R
    Greenland, K
    JOURNAL OF NEUROENDOCRINOLOGY, 1997, 9 (12) : 937 - 943
  • [22] The effect of pituitary adenylate cyclase-activating peptide-38 and vasoactive intestinal peptide in cluster headache
    Vollesen, Anne Luise H.
    Snoer, Agneta
    Chaudhry, Basit
    Petersen, Anja Sofie
    Hagedorn, Andreas
    Hoffmann, Jan
    Jensen, Rigmor H.
    Ashina, Messoud
    CEPHALALGIA, 2020, 40 (13) : 1474 - 1488
  • [23] The Role of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide in Migraine Pathogenesis
    Sokolov, A. Y.
    Osipchuk, A. V.
    Skiba, I. B.
    Amelin, A. V.
    NEUROCHEMICAL JOURNAL, 2022, 16 (01) : 31 - 38
  • [24] Neuroprotection: A comparative view of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide
    Brenneman, Douglas E.
    PEPTIDES, 2007, 28 (09) : 1720 - 1726
  • [25] The Role of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide in Migraine Pathogenesis
    A. Y. Sokolov
    A. V. Osipchuk
    I. B. Skiba
    A. V. Amelin
    Neurochemical Journal, 2022, 16 : 31 - 38
  • [26] Regulation of feeding behavior by pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) in vertebrates
    Matsuda, Kouhei
    Maruyama, Keisuke
    PEPTIDES, 2007, 28 (09) : 1761 - 1766
  • [27] Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residue
    Perret, J
    Van Craenenbroeck, W
    Langer, I
    Vertongen, P
    Gregoire, F
    Robberecht, P
    Waelbroeck, M
    BIOCHEMICAL JOURNAL, 2002, 362 (02) : 389 - 394
  • [28] Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin
    Reubi, JC
    Läderach, U
    Waser, B
    Gebbers, JO
    Robberecht, P
    Laissue, JA
    CANCER RESEARCH, 2000, 60 (11) : 3105 - 3112
  • [29] Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate
    Solano, RM
    Carmena, MJ
    Carrero, I
    Cavallaro, S
    Roman, F
    Hueso, C
    Travali, S
    LopezFraile, N
    Guijarro, LG
    Prieto, JC
    ENDOCRINOLOGY, 1996, 137 (07) : 2815 - 2822
  • [30] Selective expression of vasoactive intestinal peptide (VIP)2/pituitary adenylate cyclase-activating polypeptide (PACAP)3 receptors in rabbit and guinea pig gastric and tenia coli smooth muscle cells
    Teng, BQ
    Murthy, KS
    Kuemmerle, JF
    Grider, JR
    Makhlouf, GM
    REGULATORY PEPTIDES, 1998, 77 (1-3) : 127 - 134
12345